[go: up one dir, main page]

WO2023191236A1 - Appareil servant à stimuler des nerfs périphériques dans des mains ou des pieds - Google Patents

Appareil servant à stimuler des nerfs périphériques dans des mains ou des pieds Download PDF

Info

Publication number
WO2023191236A1
WO2023191236A1 PCT/KR2022/019040 KR2022019040W WO2023191236A1 WO 2023191236 A1 WO2023191236 A1 WO 2023191236A1 KR 2022019040 W KR2022019040 W KR 2022019040W WO 2023191236 A1 WO2023191236 A1 WO 2023191236A1
Authority
WO
WIPO (PCT)
Prior art keywords
wearing
hand
wrist
stimulation
foot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2022/019040
Other languages
English (en)
Korean (ko)
Inventor
김기원
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corporation Wabe Tree
Original Assignee
Corporation Wabe Tree
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corporation Wabe Tree filed Critical Corporation Wabe Tree
Publication of WO2023191236A1 publication Critical patent/WO2023191236A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/08—Arrangements or circuits for monitoring, protecting, controlling or indicating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems

Definitions

  • the present invention relates to a peripheral nerve stimulation device for the hand or foot, and specifically, is worn on the fingers and wrist or toes and ankles in the form of a ring or cap to transmit electrical stimulation to the nervous tissue through the skin.
  • a peripheral nerve stimulation device for the hand or foot region characterized in that it increases the stimulation effect of the peripheral nerves in the finger and wrist or toe and ankle regions where peripheral neuritis symptoms occur.
  • Diabetic peripheral neuropathy is one of the complications of diabetes. It is a disease that causes complications due to nerve damage caused by long-term diabetes. It can appear in all nervous systems, but it mainly appears in the peripheral nervous system. Distinct symptoms of peripheral neuropathy include tingling in the feet, paresthesia, numbness, and severe pain. You feel burning and numbness, and you also feel pain when you touch something soft. The pain may be so extreme that it is difficult to bear, but in some cases, it may manifest as numbness where no pain is felt at all.
  • anticancer drugs such as Oxaliplatin, Paclitaxel, or Velcade, which are widely used for colon cancer, lung cancer, breast cancer, or blood cancer, and long-term use of anticancer drugs.
  • the symptoms of peripheral neuropathy that occur during anticancer drug administration persist even during anticancer drug administration, and the symptoms persist for months or years even after anticancer drug administration ends, causing long-term pain to the patient.
  • Neuropathic pain is often accompanied by various clinical characteristics and unpleasant feelings such as abnormal paresthesia, and generally takes the form of burning, pulsing, stabbing, etc. It appears as In some cases, pain may not be felt in the area where the sensory abnormality occurs. Neuropathic pain is more diverse than non-neuropathic pain.
  • neuropathic pain may have suffered from a disease or illness in the past that causes it. These include brachial plexus avulsion, spinal cord injury, cerebrovascular accident, diabetes, shingles, and post-traumatic or postoperative neuralgia. A weak response to opioid medications is a typical feature of neuropathic pain.
  • Neuropathic pain may occur acutely or may become chronic or intractable. Once it develops chronically, psychological factors can influence symptom control. Chronic neuropathic pain may also affect the patient's temperament or personality.
  • Drug preparations such as Gabapentin and Venlafaxine have been developed to treat neuropathy as described above, but there is a problem in that neuropathy cannot be properly treated due to the low efficacy of drug treatment.
  • the present invention is a device that is worn in the form of a ring or cap on the fingers and wrist, or toes and ankles to efficiently transmit electrical stimulation to the nervous tissue through the skin.
  • the present invention was completed by developing a peripheral nerve stimulation device for the hand or foot area.
  • the present invention is a structure in the form of a ring or cap that is worn on the fingers and wrist or toes and ankles to transmit electrical stimulation to the nervous tissue through the skin,
  • the object is to provide a peripheral nerve stimulation device for the hand or foot region, which is characterized by enhancing the stimulation effect of the peripheral nerves in the finger, wrist, toe, and ankle region where neuritis symptoms occur.
  • a wearing part 20 worn on the body a plurality of stimulation members (30) fixed on the inner peripheral surface of the wearing unit (20) and for applying electrical stimulation to the body; It is characterized by including a control unit 40 for controlling the electrical signal of the magnetic pole member 30.
  • the wearing unit 20 has a plurality of fixing grooves 211 formed on the inner peripheral surface, and the wrist/ankle wearing unit 21 is worn on the wrist or ankle. )and; A plurality of fixing grooves 221 are formed on the inner peripheral surface, and finger/toe wearing portions 22 and 22' are worn on fingers or toes; It is characterized by comprising a hand/foot wearing unit (23) worn on the hand or foot.
  • the stimulation member 30 is mounted in the fixing groove 211, 221 and is electrically connected to the control unit 40 to apply electrical stimulation to the body. It is characterized by including.
  • the control unit 40 is coupled to the hand/foot wearing part 23 of the wearing part 20, and the stimulation member 30 and the connection line Each is electrically connected through (41), and one side of the connection line (41) is fixed to the stimulation member (30) fixed to the wrist/ankle wearing part (21) and the finger/toe wearing part (22, 22′). connected, and the other side of the connection line 41 is connected to the control unit 40 in a detachable manner.
  • the peripheral nerve stimulation device for the hand or foot area is a ring- or cap-shaped structure that is worn on the fingers and wrist, or toes and ankles to transmit electrical stimulation, so that the finger where peripheral neuritis symptoms occur And it can increase the stimulation effect of peripheral nerves distributed in the wrist, toes, and ankle areas.
  • Figure 1 is a diagram for explaining a ring type peripheral nerve stimulator applied to the finger and wrist according to a preferred embodiment of the present invention.
  • Figure 2 is a diagram for explaining a cap type peripheral nerve stimulator applied to the finger and wrist according to a preferred embodiment of the present invention.
  • Figure 3 is a diagram showing a state in which the ring type peripheral nerve stimulator applied to the fingers and wrist of Figure 1 is worn on a person's hand.
  • Figure 4 is a diagram for explaining a ring type peripheral nerve stimulator applied to the toes and ankles according to another preferred embodiment of the present invention.
  • Figure 5 is a diagram for explaining a cap type peripheral nerve stimulator applied to the toes and ankles according to another preferred embodiment of the present invention.
  • Figure 6 is a diagram showing a state in which the ring type peripheral nerve stimulator applied to the toes and ankles of Figure 4 is worn on a person's foot.
  • Figure 7 is a diagram showing a state in which the stimulation member is coupled to the wrist/ankle wear portion or the finger/toe wear portion in the ring type peripheral nerve stimulator according to a preferred embodiment of the present invention.
  • Figure 8 is a diagram showing a state in which the stimulation member is coupled to the wrist/ankle wear portion or the finger/toe wear portion in the ring type peripheral nerve stimulator according to another preferred embodiment of the present invention.
  • Figure 9 is an enlarged view of the control unit provided in the peripheral nerve stimulator according to the present invention.
  • the present invention refers to the term “hand or foot region” as used in the specification, meaning ‘hand region’ or ‘foot region’, and “hand region” meaning “fingers and wrists,” and “foot region” meaning “toes and ankles.” means respectively.
  • “wrist/ankle wearing part” means ‘wrist or ankle wearing part’
  • “finger/toe wearing part” means ‘finger or toe wearing part’
  • hand/foot wearing part means ‘hand or foot wearing part’.
  • “hand” means including both the ‘back of the hand and the palm’
  • ‘foot’ means including both the ‘instep and sole’.
  • the peripheral nerve stimulation device 10 for the hand or foot area includes a wearing part 20, a stimulation member 30, and a control part 40. .
  • the wearing part 20 is worn on the body, and includes a wrist/ankle wearing part 21 worn on the wrist or ankle, a finger/toe wearing part 22, 22′ worn on the fingers or toes, and a hand or foot wearing part 20. It includes a hand/foot wearing part 23 that is worn on.
  • the wrist/ankle wearing portion 21 has a ring-type structure, and the finger/toe wearing portions 22 and 22' have a ring-type or cap-type structure.
  • the wrist/ankle wearing part 21 and the finger/toe wearing part 22, 22' are formed with a plurality of fixing grooves 211, 221 on the inner peripheral surface so that a plurality of stimulation members 30 can be mounted.
  • the wrist/ankle wearable unit 21 has a cutout portion 212 formed so that it can be easily worn on the body, that is, the wrist or ankle.
  • the wrist/ankle wearing portion 21 and the finger/toe wearing portions 22 and 22' are made of stretchable elastic material.
  • the elastic material is preferably selected from synthetic resin or synthetic rubber materials with elastic properties. It is not necessarily limited to the materials listed above, and all materials with physical properties equivalent to those limited above are applicable. You can lose.
  • the wrist/ankle wearing part 21 when wearing the wrist/ankle wearing part 21 on the wrist or ankle, the wrist/ankle wearing part 21 can be easily worn on the wrist or ankle by slightly widening the gap between the cutouts 212.
  • the wrist/ankle wearing portion 21 and the finger/toe wearing portions 22, 22′ are formed of stretchable elastic material because the thickness of the user's wrist, ankle, fingers, and toes are different, and the wrist and ankle are different. This is to effectively receive electrical stimulation from the stimulation member 30 by elastically tightening the fingers and toes to ensure close contact.
  • the finger wearing parts 22 and 22' include a ring type finger wearing part 22 as shown in FIG. 1 and a cap type finger wearing part 22' as shown in FIG. 2. are distinguished.
  • the ring-type finger wearing part 22 is provided with one ring-shaped finger wearing part on the thumb, and fingers on the index finger, middle finger, ring finger, and little finger.
  • the wearing portion is structured to include two ring-shaped finger wearing portions, but the number of finger wearing portions is not necessarily limited to the number limited above, and the thumb may be provided with one or two finger wearing portions, and the thumb may be provided with one or two finger wearing portions. Except for , the remaining fingers may each be provided with three finger wearing parts. Therefore, the ring-type finger wearing part 22 has the effect of treating neuropathy in each finger joint due to the structure described above.
  • the cap type finger wearing part 22' prevents neuropathy in all finger joints by wearing the cap type finger wearing part 22' on all five fingers. There is a therapeutic effect.
  • toe wearing portions 22 and 22′ include a ring type toe wearing portion 22 as shown in FIG. 4 and a cap type toe wearing portion 22′ as shown in FIG. 5. It is divided into
  • the ring type toe wearing unit 22 is a structure in which each toe is provided with only one ring-shaped toe wearing unit. However, it is not necessarily limited to the structure shown in FIG. 4. Alternatively, each toe may be provided with a plurality of toe wearing units.
  • the cap type toe wearing part 22' prevents neuropathy in all nodes of the toes by wearing the cap type toe wearing part 22' on all five toes. There is a therapeutic effect.
  • the hand/foot wearing unit 23 is a means for stably wearing the peripheral nerve stimulator of the hand or foot area according to the present invention on the hand or foot, and includes a wrist/ankle wearing unit 21 and a finger/toe wearing unit ( It is worn on the hand or foot between 22 and 22′). That is, when worn on the hand, it is worn to cover the back of the hand and palm, and when worn on the foot, it is worn so as to cover the instep and sole.
  • the hand-wearing part worn on the hand has an open wrist and finger portion, and the foot-wearing part worn on the foot has an open ankle and toe portion.
  • the foot wearing part is formed with an extension cord 231 at the heel part so that it is stably fixed to the foot, and the extension cord 231 is formed to have elasticity so as to surround the heel of the foot.
  • the material of the hand/foot wearable portion 23 is an elastic fiber material, and specifically, it is preferably a non-woven fabric made of natural fiber or synthetic fiber material so as to be breathable.
  • the stimulation member 30 is for applying electrical stimulation to the body as shown in FIG. 7, is fixed on the fixing grooves 211 and 221 of the wearing part 20, and is connected to the control unit ( 40) and involves applying electrical stimulation to the body by being electrically connected to it.
  • Figure 7 (a) is a diagram showing the state in which the stimulation member is coupled to the wrist/ankle wear part in the ring-type peripheral nerve stimulator according to the present invention
  • Figure 7 (b) is a diagram showing the state in which the stimulation member is coupled to the wrist/ankle wearing portion. This is a diagram showing the state in which the stimulation member is coupled to the finger/toe wear part in the ring type peripheral nerve stimulator according to the invention.
  • the magnetic pole member 30 is fixed on the fixing grooves 211 and 221 of the wearing part 20, as shown in FIG. 8, and has a fixture (311) formed therein. 31) and a stimulation unit 32 that is coupled to the groove 311 of the fixture 31 and is electrically connected to the control unit 40 to apply electrical stimulation to the body.
  • the stimulation member 30 mounted inside the cap is shown in Figure 7 or Figure 8. It has a structure as shown in .
  • the stimulation member 30 is composed of electrodes, and the electrodes are arranged at regular intervals on the inner peripheral surface of the wearing unit 20.
  • the stimulation member 30 is connected to the wrist/ankle wearing unit 21 or It is electrically connected to the control unit 40 by a connection line 41 embedded in the elastic member of the finger/toe wearing unit 22, 22'.
  • the material of the magnetic pole member 30 is preferably selected from conductive metal electrode materials such as carbon electrodes, silicon electrodes, gold, silver, or platinum.
  • the stimulation member 30 uses low-voltage constant current or low-frequency current to deliver electrical stimulation to the body's nervous tissue.
  • the intensity of stimulation applied to the patient's body can be adjusted appropriately within the scope of the patient's physical condition and treatment safety.
  • the arrangement structure of the cathode electrode and anode electrode of the magnetic pole member 30 is not particularly limited and can be appropriately arranged.
  • the wrist/ankle wearable part 21 and the magnetic pole member 30 fixed to the fixing grooves 211 and 221 of the finger/toe wearable parts 22 and 22' are electrically connected to each other. This is because when individually electrically connected to the control unit 40, the connection line 41 is exposed to the outside and there is a risk of short circuit.
  • the control unit 40 is for controlling the electrical signal of the stimulation member 30 and includes a power button 42 and an intensity control button 43 to adjust the intensity of the electrical signal.
  • the intensity of the electrical signal applied to the peripheral nerve can be adjusted by selecting and touching a button with an appropriate intensity of the electrical signal among the plurality of intensity control buttons 43 provided in the control unit 40 as shown in FIG. 9 according to the patient's physical condition. It can be adjusted or adjusted by appropriately rotating the dial (not shown in the drawing), but this is only an example and various changes and modifications are possible without departing from the technical spirit of the present invention. Technicians will understand well.
  • This control unit 40 is coupled to the hand/foot wearing part 23 of the wearing part 20, and is electrically connected to the magnetic stimulation part 32 of the magnetic stimulation member 30 through the connection line 41.
  • the connection line 41 is preferably used as a wire, but is not limited to this and can be configured in various ways to transmit electrical signals.
  • the power supplied to the control unit can be battery power or general electric power.
  • connection line 41 is fixedly connected to the stimulation member 30 fixed to the wrist/ankle wearing portion 21 and the finger/toe wearing portion 22, 22′, and the other side of the connecting line 41 is connected to the control unit. It is removably connected to (40).
  • one side of the connection line 41 is connected to one of the plurality of magnetic pole members 30, and the magnetic pole members 30 are connected to each other on the wrist/ankle wearing portion 21 and the finger/toe wearing portions 22 and 22′. are electrically connected.
  • the peripheral nerve stimulation device for the hand or foot area is a ring or cap-shaped structure and is worn on the fingers and wrist or toes and ankles to transmit electrical stimulation to the skin,
  • the effect of peripheral nerve stimulation can be increased by directly stimulating the peripheral nerves distributed in the fingers, wrist, toes, and ankles where symptoms of peripheral neuritis actually occur.
  • peripheral nerve stimulation device for the hand or foot area has been described in detail with the accompanying drawings, but this is merely an example and is within the scope of the technical spirit of the present invention. Those skilled in the art will be able to understand well that various changes and modifications are possible.
  • a wearing part 20 worn on the body a plurality of stimulation members (30) fixed on the inner peripheral surface of the wearing unit (20) and for applying electrical stimulation to the body; It is characterized by including a control unit 40 for controlling the electrical signal of the magnetic pole member 30.
  • the wearing unit 20 has a plurality of fixing grooves 211 formed on the inner peripheral surface, and the wrist/ankle wearing unit 21 is worn on the wrist or ankle. )and; A plurality of fixing grooves 221 are formed on the inner peripheral surface, and finger/toe wearing portions 22 and 22' are worn on fingers or toes; It is characterized by comprising a hand/foot wearing unit (23) worn on the hand or foot.
  • the stimulation member 30 is mounted in the fixing groove 211, 221 and is electrically connected to the control unit 40 to apply electrical stimulation to the body. It is characterized by including.
  • the control unit 40 is coupled to the hand/foot wearing part 23 of the wearing part 20, and the stimulation member 30 and the connection line Each is electrically connected through (41), and one side of the connection line (41) is fixed to the stimulation member (30) fixed to the wrist/ankle wearing part (21) and the finger/toe wearing part (22, 22′). connected, and the other side of the connection line 41 is connected to the control unit 40 in a detachable manner.
  • the peripheral nerve stimulation device for the hand or foot area is a ring- or cap-shaped structure that is worn on the fingers and wrist, or toes and ankles to transmit electrical stimulation, so that the finger where peripheral neuritis symptoms occur It is an invention that has the potential to be widely used in industry because it can increase the stimulation effect of peripheral nerves distributed in the wrist, toes, and ankle areas.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

La présente invention concerne un appareil servant à stimuler des nerfs périphériques dans les mains ou les pieds, l'appareil possédant une structure d'anneau ou de capuchon et étant porté sur les doigts et le poignet ou les orteils et la cheville afin d'administrer une stimulation électrique à la peau. L'appareil stimule directement les nerfs périphériques répartis dans les doigts et le poignet ou les orteils et la cheville où se produisent réellement des symptômes de la névrite périphérique, et peut ainsi améliorer l'effet de stimulation sur les nerfs périphériques.
PCT/KR2022/019040 2022-03-30 2022-11-29 Appareil servant à stimuler des nerfs périphériques dans des mains ou des pieds Ceased WO2023191236A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020220039733A KR20230140898A (ko) 2022-03-30 2022-03-30 손 또는 발 부위의 말초신경 자극장치
KR10-2022-0039733 2022-03-30

Publications (1)

Publication Number Publication Date
WO2023191236A1 true WO2023191236A1 (fr) 2023-10-05

Family

ID=88203033

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/019040 Ceased WO2023191236A1 (fr) 2022-03-30 2022-11-29 Appareil servant à stimuler des nerfs périphériques dans des mains ou des pieds

Country Status (2)

Country Link
KR (1) KR20230140898A (fr)
WO (1) WO2023191236A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12251560B1 (en) 2019-08-13 2025-03-18 Cala Health, Inc. Connection quality determination for wearable neurostimulation systems
US12357824B2 (en) 2016-01-21 2025-07-15 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation
US12420082B2 (en) 2015-09-23 2025-09-23 Cala Health, Inc. Systems and methods for peripheral nerve stimulation in the finger or hand
US12453853B2 (en) 2013-01-21 2025-10-28 Cala Health, Inc. Multi-modal stimulation for treating tremor

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004160120A (ja) * 2002-11-11 2004-06-10 Midori Yamaguchi 指先マッサージ手袋
KR20090098541A (ko) * 2008-03-14 2009-09-17 (주)메디즌 장갑형 전극을 갖는 전기치료기
KR101068809B1 (ko) * 2011-05-16 2011-10-04 최명섭 다채널 전기 자극용 글러브 및 이를 이용한 치료 시스템
KR20190100205A (ko) * 2016-12-27 2019-08-28 아벤트, 인크. 당뇨성 말초 신경병증 치료용 물품
KR20200025684A (ko) * 2018-08-31 2020-03-10 한국기계연구원 의지자극 감각전달 장치 및 이를 이용한 의지자극 감각전달 방법

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004160120A (ja) * 2002-11-11 2004-06-10 Midori Yamaguchi 指先マッサージ手袋
KR20090098541A (ko) * 2008-03-14 2009-09-17 (주)메디즌 장갑형 전극을 갖는 전기치료기
KR101068809B1 (ko) * 2011-05-16 2011-10-04 최명섭 다채널 전기 자극용 글러브 및 이를 이용한 치료 시스템
KR20190100205A (ko) * 2016-12-27 2019-08-28 아벤트, 인크. 당뇨성 말초 신경병증 치료용 물품
KR20200025684A (ko) * 2018-08-31 2020-03-10 한국기계연구원 의지자극 감각전달 장치 및 이를 이용한 의지자극 감각전달 방법

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12453853B2 (en) 2013-01-21 2025-10-28 Cala Health, Inc. Multi-modal stimulation for treating tremor
US12420082B2 (en) 2015-09-23 2025-09-23 Cala Health, Inc. Systems and methods for peripheral nerve stimulation in the finger or hand
US12357824B2 (en) 2016-01-21 2025-07-15 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation
US12251560B1 (en) 2019-08-13 2025-03-18 Cala Health, Inc. Connection quality determination for wearable neurostimulation systems

Also Published As

Publication number Publication date
KR20230140898A (ko) 2023-10-10

Similar Documents

Publication Publication Date Title
WO2023191236A1 (fr) Appareil servant à stimuler des nerfs périphériques dans des mains ou des pieds
Fink et al. Monitoring the duration of electroconvulsive therapy seizures:'cuff'and EEG methods compared
US9283371B2 (en) Electro-stimulation system
DK2340079T3 (en) MICRO-CURRENT AND CRANE ELECTRO THERAPY STIMULATOR FOR MANAGING ANXIETY, INSUMILITY, DEPRESSION AND PAIN
KR102754775B1 (ko) 비침습 신경자극을 위한 전기 전극이 포함된 스마트 웨어러블 손목밴드
Wildemeersch et al. Objective nociceptive assessment in ventilated ICU patients: a feasibility study using pupillometry and the nociceptive flexion reflex
WO2022250318A1 (fr) Gant de massage basse fréquence
CN111569250A (zh) 一种智能人体耳朵穴位电刺激仪器
CN118718255A (zh) 一种腕戴医疗设备
CN219700826U (zh) 一种治疗或预防头痛的可穿戴设备
KR200458596Y1 (ko) 스마트 메디칼 장갑 시스템
WO2023239023A1 (fr) Dispositif de stimulation vibratoire médicale
WO2023287161A1 (fr) Dispositif portable permettant une mesure d'électromyogramme de surface
WO2019074202A1 (fr) Article de vêtement conducteur auquel un microcourant est appliqué
JPH07194711A (ja) 電気治療器用手袋
JP6140911B1 (ja) 家庭用電気治療器
CN223275779U (zh) 用于上肢康复的可穿戴柔性电极装置
WO2011155747A2 (fr) Masques, chaussettes et marchandises à porter utilisant un micro-courant
SU1519649A1 (ru) Медицинский электрод дл электростимул ции
TWI903957B (zh) 生理訊號偵測及電刺激系統、其電刺激裝置及其方法
US20200094041A1 (en) Wearable Electromyography Biofeedback Therapeutic Device
WO2024039008A1 (fr) Procédé d'application de stimulation électrique et appareil d'application de stimulation électrique pour nerfs pneumogastriques reflétant le degré de symptômes selon une mesure de biosignal
WO2023163547A1 (fr) Dispositif de stimulation non invasive
JP7465496B2 (ja) 電気刺激治療器
WO2024158159A1 (fr) Dispositif pour améliorer la capacité de régulation de glycémie à l'aide d'une stimulation électrique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22935910

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 05/02/2025)

122 Ep: pct application non-entry in european phase

Ref document number: 22935910

Country of ref document: EP

Kind code of ref document: A1